Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Bodyport
AddedMar 17, 2024
UpdatedJul 2, 2026
Bodyport

Bodyport

Seed

Preventing heart disease with innovative cardiovascular sensing technology.

Founded
2015
Accelerator
Y Combinator logoY CombinatorS15
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to predict and prevent heart disease, Bodyport is a digital therapeutics company that integrates advanced biomarker platforms into user-friendly devices. Their flagship product, a cardiovascular sensing weight scale, utilizes predictive algorithms to detect early changes in cardiac function. Initially targeting heart failure, Bodyport aims to reduce avoidable hospitalizations and healthcare costs by providing comprehensive health insights directly to patients and their care teams.

Bodyport's innovative approach has garnered attention from notable investors and healthcare professionals. The company's technology measures critical indicators such as cardiac output, congestion, and heart rate, offering a proactive solution to managing chronic conditions. By enabling early intervention, Bodyport has made a significant impact on improving patient outcomes and reducing the financial burden on the healthcare system.

Bodyport - Similar Companies

Stat Health logo

Stat Health

stat-health.com

Ventricle Health Tech logo

Ventricle Health Tech

Dynocardia logo

Dynocardia

dynocardia.care

Cardiox logo

Cardiox

cardiox.com

Pulsewave logo

Pulsewave

KardioFit logo

KardioFit

ReThink Medical logo

ReThink Medical

Starling logo

Starling

Athelas logo

Athelas

athelas.com

Vital Labs logo

Vital Labs

vitallabs.co

Corventive Health logo

Corventive Health

Heartio logo

Heartio

heartio.ai

Bloomer Health Tech logo

Bloomer Health Tech

bloomertech.com

MicroHealth logo

MicroHealth

microhealth.com

Vena Vitals logo

Vena Vitals

venavitals.com

Bodyport - Quick Facts

Who are Bodyport's competitors?

Companies similar to Bodyport include Stat Health, Ventricle Health Tech, Dynocardia and Cardiox.

When was Bodyport founded?

Bodyport was founded in 2015.

When was Bodyport's last funding round?

Bodyport's most recent funding round was for $120k (USD) in January 2015.

How much has Bodyport raised to-date?

As of Jan 1, 2015, Bodyport has raised a total of $120k (USD).

How many employees does Bodyport have?

Bodyport has 19 employees as of Oct 24, 2023.

Bodyport - Classification

Industry
  • Hardware
Ownership
  • Equity
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Health Data
  • Medical Devices
Tags
  • Healthtech
  • IoT